Sumary of Spartan Bioscience seeks creditor protection after COVID-19 rapid test issue arises:
- Smaller font Descrease article font size Larger font Increase article font size The Canadian maker of a rapid COVID-19 test has filed for creditor protection after pausing shipments of the product due to a recently identified issue with the system..
- The Ottawa-based company says it seeking protection from creditors while it restructures its operations and refines the test performance..
- Despite the challenges, Spartan says it remains committed to mobile DNA-testing technology in the fight against COVID-19..
- – Apr 20, 2020 Interim CEO Jennifer Ross-Carriere said Spartan Bioscience is a Canadian company working to protect the health and safety of all Canadians…